Home / Compliance actions / 85625

FDA Warning Letter — Vertical Pharmaceuticals, LLC

Case 85625 — FEI 3004421212

The FDA took a Warning Letter action against Vertical Pharmaceuticals, LLC on February 18, 2010 (Sayreville, NJ). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.

Action Details

Facility
Vertical Pharmaceuticals, LLC
Date
February 18, 2010
Fiscal Year
2010
Product Type
Drugs
Center
CDER
Location
Sayreville, NJ (United States)

Facility

Recent inspections

  • 1222553 (NAI Tue Sep 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1106926 (NAI Wed Sep 25 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1059217 (VAI Wed Jul 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 993082 (OAI Tue Nov 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 704957 (VAI Mon Dec 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

Other compliance actions

FDA data resources